TONY DONATO
Professor
Internal Medicine
- ProfessorInternal Medicine
- Adjunct ProfessorNutrition & Integrative Physiology
RESEARCH INTERESTS
Dr. Donato's research program spans the full translational spectrum, from cultured human and rodent cells to intact arteries to studies in older adults, unified by a central question: what drives the loss of arterial function with age, and how can it be prevented or reversed. Early in his career he refined a minimally invasive method to sample vascular endothelial cells directly from human subjects, providing some of the first direct evidence of age-related endothelial oxidative stress and its links to NF-kB activation, SIRT-1 signaling, and altered nitric oxide bioavailability. His laboratory has since defined how caloric restriction, habitual aerobic exercise, rapamycin, and AMPK activation protect the aging vasculature, and has identified novel mechanisms of arterial aging including telomere uncapping, endothelial microRNA dysregulation, and cellular senescence. More recent work extends to the interface between the vasculature and the immune system, testing the role of T cells in age-related vascular dysfunction, and to the contribution of genomic instability to senescence. In parallel, he has applied this vascular expertise to rare disease, partnering with rheumatology to characterize and treat the vasculopathy of systemic sclerosis, including studies of tetrahydrobiopterin to improve peripheral vascular function. His group employs a broad methodological toolkit, including in vivo and ex vivo measures of arterial function, pressure myography, chromatin immunoprecipitation, direct measurement of reactive oxygen species and nitric oxide in arteries, and CRISPR/Cas9 mouse models.
Building on this foundation, the laboratory's current emphasis is anti-aging drug development. Active programs include NAMPT activators that restore NAD+ through the salvage pathway, novel senolytics that clear senescent cells, and senomorphics that suppress the pro-inflammatory senescence-associated secretory phenotype. His recent NIH-funded work examines the interactions among the endothelium, the immune system, genomic instability, and cellular senescence in the loss of arterial function with age.
GRANTS
- EXTERNAL GRANT OR CONTRACTTHE ROLE OF THE HAS2 AND THE ENDOTHELIAL GLYCOCALYX IN AGE-ASSOCIATED VASCULAR DYSFUNCTION1 Jul 2023 - 30 Jun 2024
- EXTERNAL GRANT OR CONTRACTINTEGRATIVE MECHANISMS OF VASCULAR AGING RESUBMISSION15 Apr 2023 - 31 Dec 2027
- EXTERNAL GRANT OR CONTRACTSAM BLOOM FELLOWSHIP F31 - TELOMERE UNCAPPING AS A NOVEL MECHANISM FOR ENDOTHELIAL CELL SENESCENCE AND AGE-RELATED ARTERIAL DYSFUNCTION1 Feb 2023 - 31 Jan 2024
- EXTERNAL GRANT OR CONTRACTIMPROVING HEALTHSPAN THROUGH DISCOVERY OF POTENT NAMPT ACTIVATORS FROM A DNA-ENCODED LIBRARY5 Sep 2022 - 31 Aug 2025
- EXTERNAL GRANT OR CONTRACTIPA VENKETASWARA FY22 TN1 Apr 2022 - 30 Sep 2023
- EXTERNAL GRANT OR CONTRACTIMPACT OF T CELLS ON AGE-RELATED VASCULAR DYSFUNCTION: A TRANSLATIONAL APPROACH1 Sep 2020 - 31 Jan 2025
- EXTERNAL GRANT OR CONTRACTIMPACT OF T CELLS ON AGE-RELATED VASCULAR DYSFUNCTION: A TRANSLATIONAL APPROACH15 Apr 2019 - 31 Jan 2025
- EXTERNAL GRANT OR CONTRACTATM STUDYRECURSION PHARMACEUTICALS LLC3 Jan 2018 - 31 Dec 2019
- EXTERNAL GRANT OR CONTRACTIDENTIFICATION OF SENOLYTICSRECURSION PHARMACEUTICALS LLC1 Jan 2018 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTROLE OF HYALURONANNIH NATL CTR FOR COMPLMT & INT1 Jan 2018 - 31 Dec 2020
- FELLOWSHIP OR RESIDENCYIPA HOVA SALT LAKE CITY HEALTH CARE9 Jan 2017 - 31 Dec 2018
- EXTERNAL GRANT OR CONTRACTTVP SERVICE CONTRACTRECURSION PHARMACEUTICALS LLC1 Jan 2017 - 31 Dec 2018
- EXTERNAL GRANT OR CONTRACTR01: TELOMERE UNCAPPINGNIH NATIONAL INSTITUTE ON AGIN9 Jan 2016 - 31 Dec 2022
- FELLOWSHIP OR RESIDENCYIPA GATESVA SALT LAKE CITY HEALTH CARE8 Jan 2016 - 31 Dec 2017
- EXTERNAL GRANT OR CONTRACTSENOLYTICS (RECURSION PHARMA)RECURSION PHARMACEUTICALS LLC1 Jan 2016 - 31 Dec 2017
- FELLOWSHIP OR RESIDENCYIPA HENSONVA SALT LAKE CITY HEALTH CARE9 Jan 2015 - 31 Dec 2017
- EXTERNAL GRANT OR CONTRACTMTOR AND ARTERIAL AGINGAMERICAN HEART ASSN WSTRN STAT7 Jan 2015 - 31 Dec 2016
- EXTERNAL GRANT OR CONTRACTNITRIC OXIDE COUPLING AND BH4FLIGHT ATTENDANT MEDICAL RESEA7 Jan 2015 - 31 Dec 2020
- FELLOWSHIP OR RESIDENCYIPA HO HUYNHVA SALT LAKE CITY HEALTH CARE1 Jan 2015 - 31 Dec 2017
- FELLOWSHIP OR RESIDENCYIPA HOLMESVA SALT LAKE CITY HEALTH CARE1 Jan 2015 - 31 Dec 2015
- FELLOWSHIP OR RESIDENCYIPA DANIEL MACHINVA SALT LAKE CITY HEALTH CARE11 Jan 2014 - 31 Dec 2015
- FELLOWSHIP OR RESIDENCYIPA GRANT HENSONVA SALT LAKE CITY HEALTH CARE9 Jan 2014 - 31 Dec 2015
- FELLOWSHIP OR RESIDENCYIPA KELLY REIHLVA SALT LAKE CITY HEALTH CARE9 Jan 2014 - 31 Dec 2015
- FELLOWSHIP OR RESIDENCYIPA SUGATA HAZRAVA SALT LAKE CITY HEALTH CARE9 Jan 2014 - 31 Dec 2015
- EXTERNAL GRANT OR CONTRACTENDOTHEIAL ACTIVATION NAMPTNIH NATIONAL INSTITUTE ON AGIN4 Jan 2014 - 31 Dec 2019